Dean Bitan is currently, the CEO & Co-Founder of Imagene, an emerging leader in the field of precision medicine for cancer revolutionizing biomarker real-time detection to optimize treatment decisions. He constructed the first data-driven budget planning process of the Israeli Defence Force, established an AI research and services company, created an ultrasound-based communication venture, and streamlined the chain of molecular testing for precision medicine for cancer including a remote genetic consulting application, a molecular analysis platform, bioinformatics algorithms development, and a robotic arm guided by AI for DNA extraction.